Fulvia Cellani
9 Papers
132 Citations
Fulvia Cellani is an academic researcher. The author has contributed to research in topics: Endometrial Polyp & Hysteroscopy. The author has an hindex of 9, co-authored 9 publications.
Chat about Author
Papers
Accuracy of hysteroscopic diagnosis of endometrial hyperplasia: A retrospective study of 323 patients
TL;DR: Current hysteroscopic criteria suggesting endometrial hyperplasia are inaccurate are inaccurate; in order to excludehyperplasia, a pathologic assessment is warranted in all hysteroscopies showing an irregularly lined or thick endometrium.
51
Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women
TL;DR: Menopausal women with estrogen receptor-positive breast cancer appear to have high risk of baseline subclinical endometrial abnormalities; therefore, an endometrian assessment, before the start of tamoxifen therapy, is always recommended in such patients.
31
Prognostic Significance of Hysteroscopic Imaging in Endometrioid Endometrial Adenocarcinoma
TL;DR: The extent of endometrial lining involvement in patients with endometrioid carcinoma provides preoperative information on the risk of extrauterine spread and the high accuracy of hysteroscopy in excluding cervical spread is confirmed.
27
Saline Infusion Sonography and Office Hysteroscopy to Assess Endometrial Morbidity Associated with Tamoxifen Intake
Giancarlo Garuti,Fulvia Cellani,Francesco Grossi,Monica Colonnelli,Giovanna Centinaio,Massimo Luerti +5 more
TL;DR: Office hysteroscopy is a safe and conclusive diagnostic tool for endometrial investigation in menopausal women on tamoxifen and has a better feasibility rate and diagnostic accuracy than saline infusion sonography.
25
Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
Giancarlo Garuti,Fulvia Cellani,Giovanna Centinaio,Giuseppe Montanari,Giulio Nalli,Massimo Luerti +5 more
TL;DR: AIs delivered as up-front therapy for breast cancer have no effects on unspecific endometrial thickening and when administered as switched therapy after tamoxifen withdrawal, AIs may reverse tamoxIFen-associated endometrian thickening.
24